Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its isotype-specific secondary antibodies.
Therapeutic antibodies or immunoglobulins are becoming increasingly popular due to their targeted approach to treating various diseases, including cancer, autoimmune disorders, and infectious diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback